JP2018528441A5 - - Google Patents

Download PDF

Info

Publication number
JP2018528441A5
JP2018528441A5 JP2018533586A JP2018533586A JP2018528441A5 JP 2018528441 A5 JP2018528441 A5 JP 2018528441A5 JP 2018533586 A JP2018533586 A JP 2018533586A JP 2018533586 A JP2018533586 A JP 2018533586A JP 2018528441 A5 JP2018528441 A5 JP 2018528441A5
Authority
JP
Japan
Prior art keywords
capture reagent
biomarker
aptamers
antibodies
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018533586A
Other languages
Japanese (ja)
Other versions
JP6857185B2 (en
JP2018528441A (en
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2015/009552 external-priority patent/WO2017043679A1/en
Publication of JP2018528441A publication Critical patent/JP2018528441A/en
Publication of JP2018528441A5 publication Critical patent/JP2018528441A5/ja
Application granted granted Critical
Publication of JP6857185B2 publication Critical patent/JP6857185B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

前記バイオマーカー値を検出する段階は、インビトロ（ｉｎ ｖｉｔｒｏ）での検定を行う段階を含むことができる。 The step of detecting the biomarker value can include a step of performing an in vitro test.

前記インビトロ（ｉｎ ｖｉｔｒｏ）での検定は、前記バイオマーカータンパク質それぞれに対応する１つの捕捉試薬を含むことができ、前記方法は、アプタマー、抗体及び核酸プローブからなる群より少なくとも１つの捕捉試薬を選択する段階を更に含むことができる。 The in vitro assay can include one capture reagent corresponding to each of the biomarker proteins, the method selecting at least one capture reagent from the group consisting of aptamers, antibodies and nucleic acid probes. Further steps can be included.

JP2018533586A 2015-09-11 2015-09-11 Protein biomarker panel for non-small cell lung cancer diagnosis and non-small cell lung cancer diagnostic method using this Active JP6857185B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2015/009552 WO2017043679A1 (en) 2015-09-11 2015-09-11 Protein biomarker panel for detecting non-small cell lung cancer and method for diagnosing a non-small cell lung cancer by the use thereof

Publications (3)

Publication Number Publication Date
JP2018528441A JP2018528441A (en) 2018-09-27
JP2018528441A5 true JP2018528441A5 (en) 2021-03-25
JP6857185B2 JP6857185B2 (en) 2021-04-14

Family

ID=58239995

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018533586A Active JP6857185B2 (en) 2015-09-11 2015-09-11 Protein biomarker panel for non-small cell lung cancer diagnosis and non-small cell lung cancer diagnostic method using this

Country Status (4)

Country Link
JP (1) JP6857185B2 (en)
KR (2) KR102078310B1 (en)
CN (1) CN108026584B (en)
WO (1) WO2017043679A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI758670B (en) * 2018-12-24 2022-03-21 奎克生技光電股份有限公司 Health risk assessment method
CN110333341A (en) * 2019-07-04 2019-10-15 浙江理工大学 A method of silk fabric cultural relics sample is identified based on protein biochip technology

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002053592A1 (en) * 2000-12-28 2002-07-11 Shionogi & Co., Ltd. Novel polypeptide and dna thereof
US7888051B2 (en) * 2007-09-11 2011-02-15 Cancer Prevention And Cure, Ltd. Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues
WO2010105235A2 (en) * 2009-03-12 2010-09-16 Cancer Prevention And Cure, Ltd. Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy
ES2703363T3 (en) * 2008-02-01 2019-03-08 Massachusetts Gen Hospital Use of microvesicles in the diagnosis and prognosis of brain tumors
JP5701212B2 (en) * 2008-09-09 2015-04-15 ソマロジック・インコーポレーテッド Lung cancer biomarkers and their use
WO2011109440A1 (en) * 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings Biomarkers for theranostics
SG168431A1 (en) * 2009-07-23 2011-02-28 Univ Singapore Cancer biomarker and the use thereof
EP2462164A2 (en) * 2009-08-04 2012-06-13 Biosystems International SAS Lung cancer biomarkers
CN104777313B (en) * 2010-07-09 2017-09-26 私募蛋白质体公司 Lung cancer biomarkers and application thereof
JP2014519340A (en) * 2011-06-16 2014-08-14 カリス ライフ サイエンシズ ルクセンブルク ホールディングス エス．アー．エール．エル． Biomarker compositions and methods
CA2844671A1 (en) * 2011-08-08 2013-02-14 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Biomarker compositions and methods
WO2013033019A1 (en) * 2011-08-31 2013-03-07 University Of Utah Research Foundation Methods for determining the integrity of a biological sample
SG11201400375SA (en) * 2011-10-24 2014-04-28 Somalogic Inc Lung cancer biomarkers and uses thereof
MX338162B (en) 2011-10-24 2016-04-04 Hewlett Packard Development Co Fluid ejection devices and methods thereof.
WO2013152989A2 (en) * 2012-04-10 2013-10-17 Eth Zurich Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer

Similar Documents

Publication Publication Date Title
GB201816522D0 (en) Methods and reagents for analysing nucleic acids from single cells
WO2017055487A3 (en) A METHOD FOR DIAGNOSING A DISEASE BY DETECTION OF circRNA IN BODILY FLUIDS
EP3480310A4 (en) Probe for nucleic acid enrichment and capture, and design method thereof
BR112018002173B8 (en) Systems and methods using magnetic response sensors to determine a genetic trait
CA2873099C (en) Aptamer-based multiplexed assays
JP2014132019A5 (en)
EP3636769A4 (en) Sample nucleic acid measurement test kit, reagent, and application thereof
WO2015095355A3 (en) Detection of an antibody against a pathogen
EP3216852A4 (en) Method for introducing nucleic acid, method for detecting nucleic acid, method for analyzing biological component, array device for biological component assay, and kit for analyzing biological component
BR112017022329A2 (en) methods for detecting agglutination and compositions for use in practice thereof
IT201600073964A1 (en) NANO SWITCH BASED ON NUCLEOTIDES AND METHODS FOR DETECTING ANTIBODIES AND OTHER ANALYTES
BR112014026440A2 (en) assays, methods and apparatus for assessing rna disruption
WO2013166444A3 (en) Biomarker analysis using scodaphoresis
WO2015054700A3 (en) Biomarkers for predicting risk of acute ischemic stroke and methods of use thereof
WO2015023503A3 (en) Compositions and methods for multimodal analysis of cmet nucleic acids
JP2018528441A5 (en)
EP3557259A3 (en) Methods and arrays for use in the same
WO2015068075A3 (en) Detection of tau
WO2014160237A3 (en) Methods of prognosing preeclampsia
SG10201907690TA (en) Device and method for detecting target molecules
EP2998408A4 (en) Method for obtaining epigenetic cell information, method for determining cell characteristics, method for assessing drug sensitivity or selecting drug or immunotherapeutic agent variety, disease diagnosis method, self-replicating vector, assay kit, and analysis device
WO2014145243A3 (en) High resolution melting analysis assay for the detection of viral dna
WO2015038987A3 (en) System and method for whole-animal high-throughput compound screening
MX2016017048A (en) Collaborative enzyme enhanced reactive (ceer) immunoassay using flow cytometry.
AR095089A1 (en) VIRUS JC DNA DETECTION TEST